Mobile Study

Enroll Now

Type of Study:

Participants will have type 2 diabetes and be using basal insulin (with or without oral medications and/or Glucagon-Like-Peptide-1 (GLP-1) analogue) and have an elevated Hemoglobin A1C of 8.0 – 11.5.

Title of Study:

Continuous Glucose Monitoring in Type 2 Diabetes Basal Insulin Users

Short Title:

The Mobile Study

Study Length: 14 Months

Target Age/Sex: 30 or over, Male and Female

Benefits:

Participants will receive at no cost: study product, study materials and study-specific procedures

Link: https://clinicaltrials.gov/show/NCT03566693